ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 宜明昂科生物醫藥技術(上海)股份有限公司

Please note that due to the planned shutdown of Webb-site.com, the directors, officers and advisers of HK-listed companies have ceased to be updated effective 2025-03-31. Appointments and resignations effective on or before that date were recorded, as were advisers recorded in annual reports filed on or before that date. A repository of our database and software is now available.
Snapshot date:
exclude unknown removal dates

Supervisory

Name ⚥ Age
in
2022		 Position From Until
1 Gu, Jiefeng 顧傑鋒 M 39 Sup ChChairman of Supervisors 2016-03-01 2024-07-29
2 Tian, Miao (1992) 田苗 F 30 SupervisorSupervisor 2017-07-24
3 Zhao, Zimeng 趙子萌 M 31 SupervisorSupervisor 2022-01-17

Main board

Name ⚥ Age
in
2022		 Position From Until
1 Li, Song (1985) 李松 M 37 EDExecutive Director 2015-12-17
2 Smith, Kendall Arthur M 80 INEDIndependent Non-Executive Director 2022-06-14
3 Song, Ziyi 宋子一 F 38 FDFinance Director 2022-01-17 2024-03-02
4 Tian, Wenzhi (1964) 田文志 M 58 Ch, CEO, FdrChairman, Chief Executive Officer, Founder 2015-06-18
5 Xu, Cong (1986) 徐聰 M 36 NEDNon-Executive Director 2020-10-14
6 Yeung, Rex Chi Tat 楊志達 M 53 INEDIndependent Non-Executive Director 2022-06-14
7 Yu, Xiaoyong 于曉勇 M 50 NEDNon-Executive Director 2015-12-15 2024-09-30
8 Yu, Zhihua (1967) 余治華 M 55 NEDNon-Executive Director 2018-03-30 2024-10-14
9 Zhu, Zhenping 朱禎平 M 57 INEDIndependent Non-Executive Director 2016-08-03

Manager/adviser/other

Name ⚥ Age
in
2022		 Position From Until
1 Guan, Mei (1982) 關梅 F 40 CoSecCompany Secretary 2022-06-14
2 Li, Kin Wai (1988) 李健威 M 34 CoSecCompany Secretary 2022-06-14

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top